Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients

Tajinder P Singh1, Leah B Edwards, Richard Kirk

  • 1Department of Cardiology, Children's Hospital Boston, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA. tp.singh@cardio.chboston.org

Insights

Pediatric heart transplant survival has improved over time, even with sicker patients. This improvement is mainly due to better outcomes in the first six months post-transplant.

Area of Science:

  • Pediatric Cardiology
  • Transplant Surgery
  • Immunology

Background:

  • Pediatric heart transplant (HT) survival has improved in recent years.
  • Previous studies have not fully assessed the impact of transplant era on survival after accounting for baseline risk factors.

Purpose of the Study:

  • To evaluate the risk-adjusted effect of transplant era on 5-year survival in pediatric heart transplant recipients.
  • To identify factors influencing conditional 5-year survival post-transplant.

Main Methods:

  • Compared baseline characteristics and 5-year survival in 3,376 pediatric HT recipients across three eras (early, middle, recent).
  • Utilized a Cox proportional hazards model to determine risk-adjusted era effects on death or graft loss (retransplant).

Main Results:

  • Recent era recipients had a higher incidence of retransplants and pre-formed antibodies, and were more likely to require mechanical support at transplant.
  • Risk-adjusted 5-year survival was significantly better in the middle and recent eras compared to the early era.
  • Factors influencing conditional 5-year survival included recipient/donor age, gender, retransplant status, pre-formed antibodies, and inotrope use, but not the transplant era itself.

Conclusions:

  • Risk-adjusted survival in pediatric heart transplant recipients has improved over time, despite an increasing baseline risk profile.
  • The observed era effect on survival is primarily attributed to enhanced outcomes within the first six months post-transplant.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...